금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
European Central Bank: September hike risk rises with oil and PMIs – Commerzbank
Commerzbank analysts highlight that ECB President Lagarde has opened the door to a September rate hi...
Ukraine opens probe into defence event after deadly Russian strike
Rare daytime missile attack on Kyiv killed at least 10 people on Friday...
Chip stocks sell off globally after Samsung earnings disappoint
Samsung stock fell nearly 7% in South Korea despite a 19-fold surge in quarterly operating profit, dragging tech indexes lower worldwide
BlackRock to launch Nasdaq-100 ETF, challenging Invesco's dominance as AI rally boosts demand
BlackRock said on Tuesday it would launch an exchange-traded fund tracking the technology-heavy Nasdaq-100 index, as it seeks to tap surging investor demand for exposure to the AI-driven stock marke ...
CRM Stock Has Bounced From This Price Before. Now What?
After a punishing slide, Salesforce stock has landed on a price floor that has launched major rallies before, forcing investors to decide if history is a guide or a trap.
Will SpaceX Plunge Below $100 Before the End of 2026? History Provides a Decisive Answer.
History has a way of accurately forecasting the future on Wall Street.
Is Google Cloud Officially Driving the Train?
Let’s be honest. When a stock you own doubles, you feel like a genius. When it’s a behemoth like Alphabet (GOOGL), and it returns +105% in a year, you might wonder if you’ve misread the chart. You hav ...
Vale chairman Stieler resigns ahead of potential shareholder vote
Autodesk granted early termination of MaintainX deal from FTC
Highwood Asset Management announces buyback for up to 10% of public float
Top energy stocks entering Q2 earnings season, ranked by EPS revisions
Why Archer Aviation Stock Plummeted Last Month But Is Gaining in July
There wasn't much news for Archer Aviation last month. So why did the stock get crushed?
Why Palantir Stock Plummeted Last Month But Is Soaring in July
Are things finally looking up for Palantir after last month's brutal sell-off?
Compass gains on new late-stage trial data for psychedelic therapy in depression